MARSHALL WACE, LLP - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 135 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$2,521,000
-42.5%
472,137
-44.8%
0.01%
-50.0%
Q2 2021$4,383,000
-57.5%
856,053
-44.2%
0.02%
-57.4%
Q1 2021$10,317,000
+6348.1%
1,532,897
+4296.8%
0.05%
+4600.0%
Q4 2020$160,000
-94.6%
34,864
-94.3%
0.00%
-95.0%
Q4 2019$2,940,000
+9700.0%
609,935
+5720.5%
0.02%
Q3 2019$30,000
-99.8%
10,479
-98.9%
0.00%
-100.0%
Q1 2019$13,954,000
+1131.6%
984,550
+1075.7%
0.07%
+450.0%
Q4 2018$1,133,00083,7420.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders